Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 11, 2025
DURHAM, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced fourth quarter and full-year financial results for the year ended December 31, 2024, and provided its financial guidance for full-year 2025.
Read more at globenewswire.com
